These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31666402)

  • 1. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.
    Haak AJ; Kostallari E; Sicard D; Ligresti G; Choi KM; Caporarello N; Jones DL; Tan Q; Meridew J; Diaz Espinosa AM; Aravamudhan A; Maiers JL; Britt RD; Roden AC; Pabelick CM; Prakash YS; Nouraie SM; Li X; Zhang Y; Kass DJ; Lagares D; Tager AM; Varelas X; Shah VH; Tschumperlin DJ
    Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7.
    Choi KM; Haak AJ; Diaz Espinosa AM; Cummins KA; Link PA; Aravamudhan A; Wood DK; Tschumperlin DJ
    J Cell Physiol; 2021 Nov; 236(11):7759-7774. PubMed ID: 34046891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
    Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M
    J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis.
    Papavassiliou KA; Sofianidi AA; Spiliopoulos FG; Gogou VA; Gargalionis AN; Papavassiliou AG
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
    Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
    Konishi T; Schuster RM; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ activation mediates PQ-induced lung fibrosis by sustaining senescent pulmonary epithelial cells.
    Yu Y; Chu C; Wang K; Li Y; Mao Z; Hu L; Wang J; Yu Y; Sun H; Chen F
    Respir Res; 2024 May; 25(1):212. PubMed ID: 38762455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ.
    Zmajkovicova K; Menyhart K; Bauer Y; Studer R; Renault B; Schnoebelen M; Bolinger M; Nayler O; Gatfield J
    Am J Respir Cell Mol Biol; 2019 May; 60(5):578-591. PubMed ID: 30537446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
    Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D
    Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin signalling regulates YAP and TAZ to control skin homeostasis.
    Elbediwy A; Vincent-Mistiaen ZI; Spencer-Dene B; Stone RK; Boeing S; Wculek SK; Cordero J; Tan EH; Ridgway R; Brunton VG; Sahai E; Gerhardt H; Behrens A; Malanchi I; Sansom OJ; Thompson BJ
    Development; 2016 May; 143(10):1674-87. PubMed ID: 26989177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
    Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
    Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
    [No Abstract]   [Full Text] [Related]  

  • 13. Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis.
    Costa CRR; Chalgoumi R; Baker A; Guillou C; Yamaguti PM; Simancas Escorcia V; Abbad L; Amorin BR; de Lima CL; Cannaya V; Benassarou M; Berdal A; Chatziantoniou C; Cases O; Cosette P; Kozyraki R; Acevedo AC
    Sci Rep; 2024 Apr; 14(1):9497. PubMed ID: 38664418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.
    Dieffenbach PB; Haeger CM; Coronata AMF; Choi KM; Varelas X; Tschumperlin DJ; Fredenburgh LE
    Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L628-L647. PubMed ID: 28642262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine Receptor D1 Is Exempt from Transforming Growth Factor
    Gao AY; Diaz Espinosa AM; Nguyen BBN; Link PA; Meridew J; Jones DL; Gibbard DF; Tschumperlin DJ; Haak AJ
    J Pharmacol Exp Ther; 2023 Sep; 386(3):277-287. PubMed ID: 37024146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
    Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
    EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yap/Taz Deletion in Gli
    Liang M; Yu M; Xia R; Song K; Wang J; Luo J; Chen G; Cheng J
    J Am Soc Nephrol; 2017 Nov; 28(11):3278-3290. PubMed ID: 28768710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation Between Immunohistochemical Expression of Hippo Pathway Effectors and Chronic Hepatitis Induced Fibrosis in Egyptian Patients.
    Abdallah RA; Shaban MI; Taie DM; Asaad NY; Badr A
    Turk Patoloji Derg; 2020; 36(1):48-63. PubMed ID: 31282549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis.
    Santos DM; Pantano L; Pronzati G; Grasberger P; Probst CK; Black KE; Spinney JJ; Hariri LP; Nichols R; Lin Y; Bieler M; Seither P; Nicklin P; Wyatt D; Tager AM; Medoff BD
    Am J Respir Cell Mol Biol; 2020 Apr; 62(4):479-492. PubMed ID: 31944822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.